NCT04256278View on ClinicalTrials.gov

Administration of Antioxidants to Infertile Men and Sperm Quality

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

April 29, 2022

Study Completion Date

April 29, 2022

Conditions
Male Infertility
Interventions
OTHER

Spermotrend

oral administration of antioxidants for three months

Trial Locations (1)

56403

Unit of Assisted Reproduction, 1st Department of Obstetrics-Gynecology -Papageorgiou General Hospital, Thessaloniki, Greece, Thessaloniki

Sponsors

Collaborators (1)

Armatura
All Listed Sponsors
collaborator

Andrology lab Zeginiadou

UNKNOWN

collaborator

Armatura

UNKNOWN

lead

Aristotle University Of Thessaloniki

OTHER

NCT04256278 - Administration of Antioxidants to Infertile Men and Sperm Quality | Biotech Hunter | Biotech Hunter